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Background. Association between body mass index (BMI) and long-term mortality is poorly studied in older hospi-
talized populations.
Methods. The researchers prospectively studied the impact of the BMI, comorbidities, and malnutrition on long-term 
mortality in 444 patients (mean age 85.3 ± 6.7 years; 74.0% women) receiving geriatric inpatient care. All-cause mortality 
was determined using simple and multiple Cox proportional hazard models.
Results. Higher BMI was associated with a higher prevalence of diabetes, hypertension, and heart failure, but with 
a lower prevalence of malignancies. Four-year all-cause mortality was inversely associated with a BMI greater than or 
equal to 30 kg/m2 (hazard ratio = 0.59, p =  .037) and positively associated with age, male gender, several individual 
comorbidities, and the global disease load determined by the Cumulative Illness Rating scale. The inverse association 
between a BMI greater than or equal to 30 and mortality remained significant after adjustment for age, gender, smok-
ing, individual comorbidities (including heart failure and malignancies), Cumulative Illness Rating scale scores, and 
malnutrition parameters (hazard ratio = 0.52, p = .015). One-year mortality was associated with the Cumulative Illness 
Rating scale score but not with BMI categories. There were no survival differences between patients in low (<20.0) and 
intermediate (20.0–24.9 and 25.0–29.9) BMI categories.
Conclusions. A BMI greater than or equal to 30 is associated with better long-term survival in hospitalized older 
patients, even after extensive adjustment for comorbidities, malnutrition, and smoking. Conversely, a low BMI (<20–25) 
is not associated with excess mortality, likely due to the overriding impact of multiple comorbidities. The researchers’ 
observations have important implications for the mortality risk stratification in older high-risk patients.
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THE association between obesity and cardiovascular and all-cause mortality is well established. However, there 
is still uncertainty about the effect of age and comorbidities 
on this association. Large collaborative studies using the 
body mass index (BMI) to define obesity have shown 
that the mortality risk associated with obesity markedly 
declines with age (1,2). Studies in older populations have 
shown a paradoxical, inverse association between the BMI 
and survival (3–5). This inverse association was essentially 
accounted for by high mortality in patients with a low 
BMI (<20.0 kg/m2), but there was no evidence of excess 
mortality in obese patients, commonly defined by a BMI 
higher than 30.0 kg/m2 (3). Similarly, an “obesity paradox” 
has been reported in younger patients with chronic renal 
insufficiency, heart failure, or coronary heart disease 
(6,7). The underlying mechanisms remain incompletely 
understood. One possibility is that comorbidities and/
or malnutrition are associated with both mortality and 
unintentional weight loss, thereby confusing the association 
between the BMI and mortality (8,9). Another possibility is 
that a high BMI is a protective factor against mortality from 
acute diseases or comorbidities, as a higher fat or lean body 
mass may somehow offer a greater metabolic or nutritional 
reserve (6).
Older patients in medical or geriatric care represent a 
population with a particularly high prevalence of comorbid-
ities and functional disabilities. The researchers have previ-
ously observed in two prospective studies that the BMI is 
strongly associated with survival in such patients (10–12). 
One of these studies was initially conducted to determine 
the impact of cognitive disorders on adverse outcomes of 
hospitalization and mortality, relative to other risk factors 
and comorbidities; an extensive baseline characterization 
of comorbidities and long-term mortality data are therefore 
both available (13,14). In the present report, the research-
ers used the data from this cohort to determine the relative 
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impact of the BMI, comorbidities, and related factors on 
4-year all-cause mortality after a hospital admission.
Patients and Methods
The study was conducted in a 294-acute bed geriatric 
hospital where 22.7% patients were directly admitted from 
the community, 54.0% were referred from the emergency 
unit and 23.3% were transferred from other inpatient ser-
vices. Patients and data collection have been described 
previously (13). Briefly, a representative sample of all 
patients aged more than 75  years, consecutively admit-
ted between January 2004 and December 2005 were ran-
domly selected, with a sampling fraction of 30% using a 
computer algorithm. The exclusion criteria were disorders 
interfering with psychometric assessment and terminal ill-
ness. The local Ethics Committee approved the protocol, 
and patients, families, or legal representatives provided 
signed written informed consent. Demographic data for 
the patients studied did not significantly differ from those 
admitted during the recruitment period (13). Data collected 
are listed in Table 1.
Medical history was recorded on standardized forms; the 
following parameters were recorded in all patients:
1.  Age, sex, marital status, living arrangements, and cur-
rent smoking.
2. The BMI (kg/m2) was calculated from measured weight 
and height at admission. To avoid bias associated with 
acute fluid retention diseases all patients were weighted 
again 1 week after admission, the lowest weight was 
taken as the reference one. In hospital, weight was 
measured on a large scale located at the floor level 
allowing weighting of a patient while sitting on his 
wheel chair. Weight and height were measured by 
research technicians to the nearest 0.1 kg and centimeter, 
respectively, on patients wearing a hospital gown or 
light clothing before breakfast. Both measurements 
were performed later during hospitalization in patients 
initially unable to stand. Thanks to the prospective 
design of the study, height was measured on every 
follow-up visit, by the same team.
3. Comorbidities were assessed with the CIRS by 
extensive review of the patient’s medical records for 
Table 1. Patients’ Baseline Characteristics According to BMI Categories (n = 444)
BMI (kg/m2) <20 20–24.9 25–29.9 ≥30 p
n 94 179 115 56
Age (y) 86.9 (6.2) 85.3 (7.0) 84.6 (6.7) 83.3 (6.4) .011
Male gender 22.3 25.1 33.9 19.6 .132
Smoking (%) 22.3 29.6 28.7 21.4 .439
BMI (kg/m2) 17.9 (1.6) 22.6 (1.4) 27.2 (1.5) 33.2 (3.0) <.001
CIRS 14.3 (4.9) 13.9 (4.8) 15.7 (5.0) 15.4 (4.4) .010
CIRS-no DM 14.0 (4.9) 13.4 (4.7) 14.9 (4.9) 14.3 (4.1) .059
MNA 6.8 (2.6) 9.3 (2.5) 10.3 (2.3) 10.8 (2.2) <.001
MMSE 20.3 (5.8) 21.1(5.0) 21.1 (5.0) 21.4 (5.4) .603
Bedridden (%) 1.1 0.6 0.0 0.0 .791
Ischemic heart disease (%) 24.5 23.5 27.8 19.6 .681
Stroke (%) 11.7 10.6 13.0 21.4 .204
Atrial fibrillation (%) 33.0 24.0 31.3 28.6 .371
Congestive heart failure (%) 22.3 20.7 37.4 39.3 .002
Hypertension (%) 67.0 60.3 73.0 85.7 .002
Diabetes (%) 4.3 14.5 27.8 37.5 <.001
Malignancies (%) 19.2 12.3 10.4 3.6 .037
Renal insufficiency (mL/min/1.73 m2)
GFR Cockcroft–Gault % .018
 30–60 63.0 67.6 59.5 69.6
 <30 28.3 15.3 20.7 7.1
 mean ± SD 39.4 (15.8) 45.3 (16.5) 46.3 (19.4) 50.3 (17.1) .002
MDRD-4 GFR .033
 30–60 41.3 34.7 40.5 53.6
 <30 4.4 4.6 13.5 5.4
 mean ± SD 67.3 (27.0) 65.6 (23.7) 59.1 (25.2) 55.5 (18.4) .006
Anemia (%) 64.9 60.3 50.4 53.6 .146
Albumin (g/L) 32.5 (5.3) 33.3 (6.3) 33.8 (6.3) 33.9 (5.3) .387
CRP (mg/L) 42.1 (60.9) 33.9 (56.0) 34.2 (49.5) 29.2 (52.5) .522
Hemogobin (g/L) 122.7 (18.3) 123.9 (17.7) 124.4 (18.9) 126.6 (17.8) .645
Notes: Data are shown as mean ± SD or as percentage. Bold entries = statistically significant. BMI = body mass index; MNA = Mini Nutritional Assessment; 
MMSE  =  Mini-Mental State Examination; CIRS  =  Cumulative Illness Rating scale-Geriatrics; CIRS-no DM  =  CIRS modified score, without diabetes; 
CRP = C-reactive protein; GFR = glomerular filtration rates.
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diagnoses established at or before enrolment in this 
study. This scale has previously been validated in the 
hospital, and shown to predict length of stay, institu-
tionalization, intrahospital death, and long-term mor-
tality (14). The CIRS incorporates medical conditions 
according to 14 categories (heart disease, hyperten-
sion, hematopoietic, respiratory, eyes and ears, upper 
gastrointestinal, lower gastrointestinal, liver, kidneys, 
genitourinary, musculoskeletal, neurological, endo-
crine-metabolic, psychiatric-dementia), rated on a 
scale from 0 to 4. The total score (CIRS score) is cal-
culated as the sum of the 14 scores. As diabetes is con-
sidered as a comorbidity in the endocrine-metabolic 
category, a modified score (CIRS-no DM) omitting 
this category was calculated. It is important to note 
that obesity was not included as a comorbidity item in 
this category, contrary to the instructions provided in 
the users’ manual (19).
4. Arterial hypertension was defined by a physician diag-
nosis and/or ongoing treatment. The diabetes status was 
abstracted from the Charlson index, and verified by 
individual chart review (12). Ischemic heart disease was 
defined as myocardial infarction based on previous med-
ical history and/or ongoing treatment and was confirmed 
by revision of individual hospital charts. Stroke was 
identified by history and physical examination, and con-
firmed by cerebral imaging. The presence of atrial fibril-
lation was determined by standard ECG at admission. 
Congestive heart failure was abstracted from the ICED 
score (15). The presence of malignancy was abstracted 
from the Charlson score, combining “solid tumor with 
metastasis,” “lymphoma,” and “leukemia” into a single 
parameter.
5. The short version of the MNA-SF was administered, 
considering the 2 weeks prior admission as the reference 
period (16,17). A  score 12–14 indicates normal nutri-
tional status, 8–11  “at risk of malnutrition,” and 0–7 
malnutrition.
6. Hemoglobin, serum albumin, C-reactive protein, and 
creatinine were determined by standard techniques. The 
GFR was calculated using both the Cockcroft–Gault for-
mula adjusted for body surface area and the 4-parameter 
Modification of Diet in Renal Disease formula, as previ-
ously described (18).
The outcome of interest was death from any cause by 
December 31, 2009. Information was obtained through 
access to the population registry of the State of Geneva.
Statistical Methods
Comparison among the four BMI categories was per-
formed using one-way analysis of variance or the Kruskal–
Wallis nonparametric analysis of variance for continuous 
variables and the χ2 test for binary variables. Survival data 
were analyzed using univariate and multiple Cox models 
taking into account the time to the event. Kaplan–Meier 
survival curves were compared using the log-rank test. 
Results are presented as mean ± SD. Stata version 12 was 
used for all analysis and p < .05 was considered statistically 
significant.
Results
Patients’ Characteristics According to BMI Categories
Of the 496 randomly selected patients, 52 were excluded 
(20 major behavioral problems, 9 unable to communicate, 
8 terminally ill, 7 lived outside the state of Geneva, 5 with 
no family or legal representative), and 3 with incomplete 
data. Overall, 444 (90%) patients had full data and were 
included in this study (mean age 85.3 ± 6.7 years; 74.0% 
women). The mean BMI was 24.1 + 4.9 kg/m2. Thus, 94, 
79, 115, and 56 patients had a BMI less than 20, 20–24.9, 
25–29.9, and greater than or equal to 30 kg/m2, respectively. 
The patients’ characteristics according to BMI categories 
are shown in Table  1. Patients with a higher BMI were 
significantly younger. They had a higher prevalence of 
diabetes, hypertension, and congestive heart failure, but 
the researchers observed no significant difference in the 
prevalence of other vascular comorbidities. The prevalence 
of chronic renal insufficiency was higher in obese patients 
when estimated by the 4-parameter Modification of Diet 
in Renal Disease formula and lower when estimated by 
the Cockcroft–Gault formula, likely reflecting biases 
introduced by age, gender, and body weight in the 
estimation of GFR by these formulas. The prevalence of 
malignancies was significantly lower in the higher BMI 
categories. Patients with a higher BMI had a higher global 
comorbidity load as judged from the CIRS score. This 
higher score was accounted for by the higher prevalence of 
diabetes, as there was no significant difference in CIRS-no 
DM scores, that is, after exclusion of the endocrine/
metabolic category. The differences in MNA scores across 
BMI categories were expected, as the BMI is a major item 
of this score. There were no significant differences in the 
gender ratio and the prevalence of smoking across BMI 
categories.
All-Cause Mortality According to BMI Categories
Of the 444 patients included, 23 (5.2%) had died during 
their hospital stay, 97 (22%) and 225 (51%) had died 1 and 
4 years after discharge, respectively. Mortality according to 
BMI categories is shown in Figure 1. Survival in patients 
with a BMI greater than or equal to 30 kg/m2 was signifi-
cantly better than in lower BMI categories (<20 kg/m2, 
20–24.9 kg/m2, and 25–29.9 kg/m2; p = .05 when comparing 
all four categories and p =  .013 when comparing patients 
with a BMI > 30 kg/m2 to the three lower categories com-
bined, by the log-rank test). Importantly, there were no 
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survival differences between patients from the three lower 
BMI categories. The analysis was repeated by BMI quar-
tiles rather than by predetermined categories. Again, sur-
vival was significantly better (p =  .011) in patients in the 
highest quartile (BMI > 27.2 kg/m2), without any significant 
differences in survival between the three lower quartiles 
(<20.6, 20.6–23.4, >23.4–27.2 kg/m2).
In simple Cox models, 4-year all-cause mortality was 
inversely associated with a BMI higher than 30 kg/m2. It 
was also predicted by age, male gender, serum albumin, 
CIRS score, GFR, congestive heart failure, atrial fibrilla-
tion, and malignancies, but not by MNA scores, other indi-
vidual comorbidities and smoking (Table  2, model 0). In 
a multiple model adjusting for individual comorbidities, 
a BMI higher than 30 kg/m2 remained strongly, inversely 
associated with mortality (model 1). The researchers next 
attempted to adjust for combined comorbidities and malnu-
trition by generating a model including CIRS scores, MNA 
scores, and serum albumin (model 2). A BMI higher than 
30 kg/m2 remained strongly associated with 4-year mor-
tality, along with CIRS scores, but not with MNA scores 
or serum albumin. Finally when individual comorbidities, 
CIRS scores, MNA scores, and serum albumin and smok-
ing were all included in the model (model 3), a BMI higher 
than 30 kg/m2 remained strongly, inversely associated 
with 4-year mortality. To exclude a gender selection bias, 
the analysis was repeated in women only. In the complete 
multiple model (model 3 as defined earlier, restricted to 
women), mortality was associated with a BMI higher than 
30 kg/m2 (hazard ratio [HR] = 0.48, p = .02), as well as with 
age (HR = 1.05, p =  .005) and CIRS scores (HR = 1.07, 
p = .002). Interestingly, diabetes was associated with 4-year 
mortality both in simple (HR = 1.50, p = .048) and in mul-
tiple models (HR = 1.58, p = .047), that is, with or without 
adjustment for BMI, malnutrition, and comorbidities. The 
Cox analysis was repeated using BMI quartiles, with very 
similar results. Four-year mortality was inversely associated 
with a BMI in the highest quartile (>27.2 kg/m2; HR = 0.61, 
p = .016), and positively associated with age (HR = 1.05, 
p =  .001), male gender (HR = 1.65, p =  .001), and CIRS 
scores (HR = 1.09, p < .0001).
One-year mortality was not associated with a BMI higher 
than 30 kg/m2. However, in a complete Cox model (model 3 
as defined in Table 2) it was associated with age (HR = 1.05, 
p = .017), CIRS scores (HR = 1.15, p < .0001), and serum 
albumin (HR = 0.96, p = .042), but with none of the indi-
vidual comorbidities.
Discussion
The main finding of this study is that 4-year all-cause 
mortality is strongly, inversely associated with obesity 
defined by a BMI higher than 30 kg/m2, or even with a 
BMI higher than 27.2 kg/m2 in older patients admitted for 
hospital care. This “obesity paradox” appears not to be 
explained by the negative impact of associated comorbidi-
ties. Indeed, the prevalence of vascular comorbidities, dia-
betes, and CIRS scores were comparable or even higher 
in obese patients. The prevalence of malignancies was 
inversely associated with BMI categories, but malignancies 
failed to account for the “protective” effect of a high BMI, 
likely due to their comparatively low overall prevalence. 
Further, the association of the BMI with survival persisted 
after adjustment for age, gender, comorbidities (whether 
assessed individually or by the CIRS score), malnutrition, 
and smoking, and thus could not be accounted for by these 
parameters. Finally, it is important to note that unlike CIRS 
scores, the BMI was not associated with 1-year mortality. 
The association of a high BMI with survival is observed 
over a longer time period than the association between 
CIRS scores and mortality.
Many studies have shown an inverse association 
between mortality and the BMI in older community-
dwelling populations and in nursing home residents. 
However, most of these have actually shown an increased 
mortality in patients with a low BMI (typically <20 kg/m2), 
with no or an only modest survival advantage associated 
with a high BMI (typically >27–30 kg/m2) (3,20–24). 
Thinggaard and colleagues showed in a large cohort 
aged 70–95  years a trend to a decreasing association 
between mortality and high BMI with advancing age 
(25). In contrast to these previous studies, the researchers’ 
report focuses on older hospitalized patients with a very 
high prevalence of comorbidities and/or malnutrition, as 
evidenced by the high CIRS scores and the low MNA 
scores, and the high prevalence of vascular comorbidities, 
anemia, and hypoalbuminemia. The researchers observed 
no differences in survival among the three lower BMI 
categories. This result is actually in agreement with the 
previous observations on older inpatients from similar 
hospital services (10). In a nursing home study with a 
1-year follow-up Kaiser and colleagues found the lowest 
Figure  1. Kaplan–Meyer survival curves according to body mass index 
(kg/m2) categories (orange: >30; green: 25–29.9; red: 20–24.9; blue: >20). 
Survival was significantly better in patients with a body mass index > 30 (log-
rank test: p = .013).
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mortality in the obese group (26). The absence of excess 
mortality in patients with a BMI less than 20 kg/m2 may be 
due to the strong impact of comorbidities (not necessarily 
associated with weight loss) on mortality also in the 
higher BMI categories. In simple words, the impact of 
comorbidities overshadows the impact of low body weight 
or weight loss. However, this explanation does not account 
for the survival advantage of patients with a high BMI. An 
“obesity paradox,” defined by better survival in “obese” 
patients (BMI > 30 kg/m2) than in “normal” (20–24.9 kg/
m2) or even “overweight” (BMI 25–29.9 kg/m2) patients, 
has been reported in congestive heart failure, coronary 
heart disease, or chronic renal insufficiency (6,27–30). The 
obesity paradox observed in the study strikingly resembles 
the one seen in younger patients with severe disease(s), 
and seems distinct from the association of a low BMI with 
mortality in community-dwelling older subjects.
The mechanisms underlying this obesity paradox remain 
incompletely understood. Smoking could be involved by 
favoring both weight loss and mortality, but the observa-
tions were unaffected by adjustment for smoking. Because 
of better survival in women, the obesity paradox could 
be explained by a shift in the gender ratio across BMI 
categories. However, it was confirmed when the analysis 
was restricted to women. The negative impact of obesity 
in younger adults is in part mediated by dyslipidemia and 
hypertension. The association between obesity and these 
risk factors progressively weakens with age (31). This 
explanation may account for a weak or absent, but not for an 
inverse association between obesity and mortality. Another 
proposal is that the adipose tissue mass remains associated 
with mortality or cardiovascular disease, but is no longer 
appropriately reflected by the BMI (32). Yet, it is hard to 
imagine an inverse association between BMI and adipose 
tissue mass that would account for the obesity paradox. 
Unintentional weight loss has been associated with long-
term mortality in numerous studies (8,33,34). The obesity 
paradox could thus be explained by the effect of disease-
related weight loss on both the BMI and mortality. In the 
context of the study, the group with the highest BMI would 
be the one where significant weight loss is least likely to 
have occurred. Disease-related weight loss most probably 
accounts for the higher prevalence of malignancies in the 
lower BMI categories. However, many other comorbidi-
ties such as diabetes, hypertension, and heart failure were 
more frequent in the higher BMI categories, and the overall 
prevalence of comorbidities was similar or even higher in 
the higher BMI categories. Thus, better survival in patients 
with a high BMI is not accounted for by a lower disease 
load. The distinct effect of weight loss and comorbidities 
is also indirectly supported by the observation that weight 
gain is associated with better survival in patients with car-
diovascular disease (34). Indeed, this “mirror image” obser-
vation can hardly be explained by recovery from disease. 
Finally, the researchers have to consider the possibility that 
obesity is a protective factor against mortality from acute 
diseases or comorbidities in the short term, even though it is 
an atherogenic risk factor in the long term. A higher adipose 
tissue or muscle mass may constitute a “nutritional reserve” 
when facing disease and/or malnutrition (6).
The strengths of this study are the random patient selection 
procedure, the extensive characterization of comorbidities, 
and complete long-term mortality follow-up. The researchers’ 
study has several limitations: body composition is missing 
for this cohort. The protective effect of higher BMI level 
might not be explained by an increased amount of adipose 
tissue, but rather by a higher level of lean mass (24). Several 
comorbidities were assessed retrospectively by chart review, 
leading to possible patient misclassification with respect to 
individual comorbidities. For instance the diagnosis of heart 
failure was not confirmed by echocardiography. However, 
these inaccuracies are unlikely to affect the conclusions, 
as they would be expected to affect the assessment of all 
patients, irrespective of their BMI category. In addition, 
functional and cognitive assessments were not included in 
these analyses. A previous article on the same cohort, which 
analyzed the etiology and severity levels of cognitive status, 
showed that dementia was not predictive of short or long 
term mortality (35). The role of renal function impairment 
remains uncertain, as the estimations of the GFR based 
on serum creatinine are biased by age, gender, and body 
weight and height. In the analysis a higher BMI was 
associated with a lower GFR calculated by the 4-parameter 
Modification of Diet in Renal Disease formula, and a higher 
GFR calculated by the Cockcroft–Gault formula. The latter 
was used in the mortality analysis, to favor the hypothesis 
that comorbidities account for the obesity paradox.
Irrespective of the underlying mechanisms, the research-
ers’ observations have several practical implications. The 
obesity paradox may not be limited to mortality. Indeed, 
recent studies have suggested that in high-risk older persons 
obesity is associated with a lower prevalence of functional 
disabilities (26). It follows that the screening for obesity 
(at least as defined by a BMI ≥ 30 kg/m2) in hospitals or in 
nursing homes (36) is unlikely to identify high-risk popula-
tions, whether in terms of survival or functional capacities. 
Similarly, the inclusion of obesity in comorbidity scales such 
as the CIRS is unlikely to contribute to their performance 
as prognostic tools (19). The absence of survival difference 
between patients from the three lower BMI categories also 
has important implications. The researchers have previously 
shown that malnutrition, as diagnosed by the MNA, fails to 
predict mortality in old hospitalized patients (11). The MNA 
and other malnutrition diagnostic tools include a low BMI as 
an essential criterion. The present data suggest that the ina-
bility of these tools to predict survival is related to the lack 
of survival difference between the lower BMI categories. In 
older hospitalized patients, the high prevalence of comor-
bidities may put all patients with a BMI less than 27–30 kg/
m2 at the same high risk of all-cause death.
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